Mumbai, India
Mumbai, India

Time filter

Source Type

Patent
Glenmark Generics LTD | Date: 2010-03-18

The present invention relates to processes for the preparation of indiplon and its polymorphic mixtures.


Patent
Glenmark Generics Ltd | Date: 2013-08-28

A process for the preparation of teneligliptin.


Patent
Glenmark Generics Ltd | Date: 2013-08-06

Provided is a process for the preparation of linagliptin of Formula I, comprising deprotecting a compound of Formula II wherein R_(1 )and R_(2 )together with the nitrogen to which they are attached form a phthalimido group, wherein the aromatic ring of the phthalimido group is substituted with one or more R_(3 )substituents selected from the group consisting of halogen, alkyi, nitro and amino; or R_(1 )is H and R_(2 )is selected from the group consisting of trialkylsilyl, 2-trialkylsilylethoxycarbamates, acetyl, trihaloacetyl, 9-fluorenylmethoxycarbonyl, trityl, alkylsulfonyl, arylsulfonyl, diphenylphosphine and sulfonylethoxycarbonyl.


The present invention provides a process for the preparation of substituted 3-hydrazino-biphenyl-3-carboxylic acid compounds. The present invention further provides a process for the preparation of 3-{N-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidene]hydrazino}-2-hydroxybiphenyl-3-carboxylic acid, its intermediate compounds and pharmaceutically acceptable salts thereof.


Patent
Glenmark Generics Ltd | Date: 2013-01-17

The present invention provides a process for preparation of fingolimod, a compound of Formula I or a pharmaceutically acceptable salt thereof, free of regioisomeric impurity compound of Formula IA


Patent
Glenmark Generics Ltd | Date: 2010-03-30

The present invention relates to the purification and particle size of eslicarbazepine acetate. The present invention also relates to the physical characteristics of solid state eslicarbazepine acetate, and pharmaceutical compositions containing the same.


Patent
Glenmark Generics Ltd | Date: 2012-03-23

An aqueous gel composition of the present invention comprising about 0.1 to 0.3 wt % adapalene and about 2.5 to 5.0 wt % benzoyl peroxide, as active ingredients, wherein both the active ingredients are stabilized in hydrophilic gelling matrix of pH dependent gelling agent comprising crosslinked, acrylic acid-based polymer(s).


Patent
Glenmark Generics Ltd | Date: 2010-04-28

The present invention relates to a process for the preparation of esomeprazole magnesium containing R-isomer greater than about 0.1% by wt. In particular, the present invention relates to a process for the preparation of esomeprazole magnesium dihydrate containing R-isomer greater than about 0.1% by wt.


Patent
Glenmark Generics Ltd. | Date: 2010-03-16

The present invention relates to amorphous form of bazedoxifene acetate and a process for the preparation thereof.


Patent
Glenmark Generics Ltd. | Date: 2013-09-11

Disclosed herein is a stable pharmaceutical composition comprising a substrate having deposited on its surface a layer comprising saxagliptin or pharmaceutically acceptable salts thereof, wherein a seal coat is not present between the substrate and the saxagliptin layer.

Loading Glenmark Generics Ltd. collaborators
Loading Glenmark Generics Ltd. collaborators